Harmon Cyrus sold OLMA
December 22, 2025 · Form 4 insider transaction
Harmon Cyrus sold 2,881 shares of Olema Pharmaceuticals, Inc. at $28.53 per share, a transaction worth $82.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 7 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,881
Price
$28.53
Total value
$82.2K
InsiderHarmon Cyrus
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 22, 2025
Filing dateDecember 29, 2025
Shares owned after741,259
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The weighted average sale price for the transaction reported was $28.53, and the range of prices was between $28.50 and $28.53. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.